Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Conference Call March 4, 2024 5:00 PM ET

Company Participants

Priyam Shah - Head, IR

Brian McKelligon - CEO

Johnny Ek - CFO

Conference Call Participants

Subbu Nambi - Guggenheim

Kyle Mikson - Canaccord

Tejas Savant - Morgan Stanley

John Sourbeer - UBS

Mark Massaro - BTIG

Rachel Vatnsdal - JP Morgan

Operator

Good day and thank you for standing by. Welcome to the Akoya Biosciences Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I'll now hand the conference over to your first speaker today, Priyam Shah, Head of Investor Relations. Please go ahead.

Priyam Shah

Thank you, Operator, and thank you to everyone who is joining us today on this call. I'm Priyam Shah, Head of Investor Relations at Akoya Biosciences. On the call today, we have Brian McKelligon, Chief Executive Officer; and Johnny Ek, Chief Financial Officer.

Earlier today, Akoya released financial results for the fourth quarter ended December 31, 2023. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of Federal Securities Laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.

Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with the Akoya's business, please refer to the risks identified in our filings with the U.S. Securities and Exchange Commission, including in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2023, to be filed today March 4, 2024. We urge you to consider these factors. And you should be aware that these statements are considered estimates only and are not a guarantee of future performance.

This conference call contains time-sensitive information and is accurate only as of the live broadcast today, March 4, 2024. Akoya disclaims any intention or obligation, except as required by law to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. The audio portion of this call will be archived on the Investors section of our website later today under the heading, Events.